[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Comment & Response
November 6, 2013

Acute Ischemic Stroke and Timing of Treatment—Reply

Author Affiliations
  • 1Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California
  • 2Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California
  • 3Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts
JAMA. 2013;310(17):1856-1857. doi:10.1001/jama.2013.278898

In Reply Dr Radecki raises the interesting question of whether inclusion in the GWTG-Stroke registry cohort of a small proportion of patients who actually had stroke mimicking conditions or TIAs might have inflated the study’s estimates of the relationship of onset to lytic treatment time and clinical outcome. The available evidence indicates it did not.

First, patients whose final diagnosis was a stroke mimicking condition were not included in the GWTG-Stroke registry during the study period, even if they had received thrombolysis, so their contribution to the data was negligible.

First Page Preview View Large
First page PDF preview
First page PDF preview